All Pharma articles – Page 27
-
NewsDrug firms accused over NHS charges
Drug companies could face investigation following allegations that they are inflating the cost of drugs sold to the NHS.
-
NewsCall for change to drug price rules
Progress towards personalised medicines is being held back by the way drug prices are set, it is claimed.
-
HSJ Local
Western Sussex rolls out antibiotic prescribing app
PERFORMANCE: Pharmacy staff at Western Sussex Hospitals NHS Foundation Trust have helped develop an app for prescribing antibiotics.
-
HSJ KnowledgeGetting the best value from drug development
Determining which therapies deliver distinctive value
-
CommentThe government's drug pricing policy is still full of holes
The DH’s ambition isn’t matched by its action
-
HSJ KnowledgeFixing the crisis of trust between the NHS and Big Pharma
Lessons from the latest leadership books
-
HSJ KnowledgeShifting to a sustainable healthcare environment
The impact of climate change on healthcare
-
NewsNew NICE chair prioritises multiple conditions, care and money
The new chair of the National Institute for Health and Care Excellence has set out his priorities in the role in an interview with HSJ.
-
SupplementsAnaphylaxis − an HSJ supplement
HSJ’s in-depth supplement examines an area of care often overlooked by commissioners
-
SupplementsTalking is the best medicine - an HSJ roundtable
How the NHS can get the most out of medicines
-
HSJ PartnersHSJ webinar: the challenges of introducing new medicines to the NHS
Register to view our free webinar
-
CommentPodcast: Medicines optimisation in the new NHS
Charles Alessi and Malcolm Qualie discuss how to get the best out of the drugs budget
-
NewsDrug firms accused of pay-for-delay deal
Drugs giant GlaxoSmithKline has been accused by the competition watchdog of paying firms to delay the launch of cheaper versions of its antidepressant treatment, in a move which denied the NHS “significant” cost savings.
-
NewsSome cancer drugs taken off fast track funding list, NHS England admits
NHS England today confirmed that it had taken some cancer treatments off its “fast track” list following changes to the cancer drugs fund announced yesterday.
-
NewsHMRC investigating trusts over drug tax schemes
HM Revenue and Customs is examining hospital trusts’ tax arrangements amid a growing trend to lawfully avoid paying VAT on outpatient drugs, HSJ has learned.
-
NewsInnovators 'must provide more evidence' about product effectiveness
Pharmaceutical and technology companies looking to introduce their products into the NHS must do more research to demonstrate effectiveness, a senior NHS Commissioning Board official has said.
-
HSJ Local
SHIP cluster to save £10m through medicines management
FINANCE: The Southampton, Hampshire, Isle of Wight and Portsmouth primary care trust cluster expects to save £10.2m through medicines management this year.
-
NewsPCTs set up rebate deals despite DH opposition
At least 30 per cent of primary care trusts are defying the Department of Health to set up discount deals with pharmaceutical companies, an HSJ investigation has found.
-
NewsAnalysed: primary care rebate schemes
This week’s HSJ Briefing looks at primary care rebate schemes which, it is hoped, will lead to savings on drugs bills
-
News
ABPI to discuss NICE role in bid to break pricing deadlock
The government is to hold talks with the pharmaceutical industry on the role of the National Institute for Heath and Clinical Excellence, in a bid to reach agreement on new pricing arrangements.